Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.
Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.
复制标题
DOI:
10.1002/pros.24071
复制
发表时间:
2020-12
期刊:
影响因子:
--
通讯作者:
Mimata H
中科院分区:
文献类型:
--
作者:
Mizoguchi S;Mori K;Shin T;Wang Z;DeFranco DB;Yoshimura N;Mimata H
Dutasteride administration reportedly improves lower urinary tract symptoms in patient with chronic, histologically-identified prostatic inflammation, potentially through estrogen receptor β (ERβ), activation of which has anti-inflammatory effects in the prostate tissue. Therefore, we investigated the effect of dutasteride on intraprostatic inflammatory responses and bladder activity using a rat model of chemically induced prostatic inflammation. Male SD rats at 10 weeks old were used. Prostatic inflammation was induced by 5% formalin injection into ventral lobes of the prostate and saline was injected in the control group (Control, n=5). Rats with prostatic inflammation were divided into dutasteride therapy (Dutasteride, n=5) and placebo groups (Placebo, n=5). Dutasteride was administrated at a dose of 0.5mg/kg daily from 2 days before induction of prostatic inflammation whereas Placebo rats received vehicle only. Twenty-eight days later, cystometry was performed in a conscious condition to measure non-voiding contractions (NVCs), intercontraction intervals (ICI) and postvoid residual volume (RV). After cystometry, the prostate was excised for analysis of mRNA expression levels of ERα, ERβ, IL-1β and IL-18 by qPCR. The mean number of NVCs was significantly greater in Placebo group than that of Control group without prostatic inflammation (P<0.05), and ICI were significantly decreased in Placebo group compared to Control group (P<0.05). On the contrary, there was no significant change in NVCs or ICI between Control and Dutasteride groups. RV was not significantly different among three groups. Gene expression levels of ERα, IL-1β and IL-18 was significantly increased in Placebo rats compared to Control rats (P<0.05), but not significantly different between Control and Dutasteride rats. On the other hand, the mRNA expression level of ERβ was significantly decreased in Placebo rats (P<0.05), but not in Dutasteride rats, compared to Control rats. Dutasteride treatment improved not only prostatic inflammation evident as increased gene expression levels in IL-1β and IL-18, but also bladder overactivity shown by increased NVCs during bladder filling. These therapeutic effects were associated with the restored expression of anti-inflammatory ERβ. Therefore, dutasteride might be effective via ERβ modulation for the treatment of prostatic inflammation in addition to its previously known, anti-androgenic effects on benign prostatic hyperplasia.
登录
查看更多内容
影响因子:
2.8
作者:
Funahashi, Yasuhito;O'Malley, Katherine J.;Kawamorita, Naoki;Tyagi, Pradeep;DeFranco, Donald B.;Takahashi, Ryosuke;Gotoh, Momokazu;Wang, Zhou;Yoshimura, Naoki
通讯作者:
Yoshimura, Naoki
影响因子:
6.6
作者:
Dupont, MC;Spitsbergen, JM;Steers, WD
通讯作者:
Steers, WD
影响因子:
6.6
作者:
Vera, PL;Meyer-Siegler, KL
通讯作者:
Meyer-Siegler, KL
影响因子:
3.7
作者:
Cook LC;Hillhouse AE;Myles MH;Lubahn DB;Bryda EC;Davis JW;Franklin CL
通讯作者:
Franklin CL
影响因子:
23.4
作者:
Nickel, J. Curtis;Roehrborn, Claus G.;Rittmaster, Roger S.
通讯作者:
Rittmaster, Roger S.